Literature DB >> 8180954

Strong promoting effect of Opisthorchis viverrini infection on dimethylnitrosamine-initiated hamster liver.

W Thamavit1, C Pairojkul, D Tiwawech, T Shirai, N Ito.   

Abstract

Continuous administration of dimethylnitrosamine (DMN) to Syrian hamsters infected with the liver fluke, Opisthorchis viverrini (OV) results in a 100% incidence of cholangiocellular carcinomas. In a two-stage experiment, however, dosing with liver flukes caused only a few lesions to develop (Flavel, D.J. and Lucus, S.B. (1983) Carcinogenesis, 4, 927]. To clarify this anomaly, Syrian hamsters were initiated with 20 mg/kg DMN injected i.p. 19 days prior to 80 OV metacercaria infection. At 45 weeks, the animals receiving both DMN and the parasite demonstrated a 44% incidence of cholangiocarcinomas, a 93% incidence of cholangiofibrosis, a 35% incidence of mucous cystadenomas and a 98% incidence of hepatocellular nodules with an average number of 9.1 +/- 4.1 per animal. Animals receiving DMN alone developed 85% hepatocellular nodules with an average number of only 3.0 +/- 2.7 and no bile duct lesions. In the parasite alone group, only cholangiofibrosis was detected in a few animals and no lesions were encountered in untreated controls. These results thus demonstrate that the post-initiation influence of Opisthorchiasis is indeed effective in promoting the development of both cholangiolar and hepatocellular lesions initiated by DMN.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180954     DOI: 10.1016/0304-3835(94)90040-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

1.  Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma.

Authors:  Pakkayanee Sudsarn; Thidarut Boonmars; Wipaporn Ruangjirachuporn; Nisana Namwat; Watcharin Loilome; Pranee Sriraj; Ratchadawan Aukkanimart; Wonkchalee Nadchanan; Songsri Jiraporn
Journal:  Pathol Oncol Res       Date:  2015-08-16       Impact factor: 3.201

Review 2.  Animal models of cholangiocarcinoma.

Authors:  Emilien Loeuillard; Samantha R Fischbach; Gregory J Gores; Sumera Rizvi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-04-05       Impact factor: 5.187

3.  Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis.

Authors:  Kanuengnuch Muenphon; Temduang Limpaiboon; Patcharee Jearanaikoon; Chawalit Pairojkul; Banchob Sripa; Vajarabhongsa Bhudhisawasdi
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

Review 4.  Liver flukes: the malady neglected.

Authors:  Jae Hoon Lim
Journal:  Korean J Radiol       Date:  2011-04-25       Impact factor: 3.500

5.  Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.

Authors:  S Chariyalertsak; V Sirikulchayanonta; D Mayer; A Kopp-Schneider; G Fürstenberger; F Marks; K Müller-Decker
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

6.  Risk factors for hilar cholangiocarcinoma: a case-control study in China.

Authors:  Wen-Ke Cai; Hui Sima; Ben-Dong Chen; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

7.  Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma.

Authors:  Kanuengnuch Kosriwong; Trevelyan R Menheniott; Andrew S Giraud; Patcharee Jearanaikoon; Banchob Sripa; Temduang Limpaiboon
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

Review 8.  Co-infections with liver fluke and Helicobacter species: A paradigm change in pathogenesis of opisthorchiasis and cholangiocarcinoma?

Authors:  Banchob Sripa; Raksawan Deenonpoe; Paul J Brindley
Journal:  Parasitol Int       Date:  2016-12-03       Impact factor: 2.230

Review 9.  Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma.

Authors:  Alphonse-E Sirica
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

Review 10.  The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer.

Authors:  Banchob Sripa; Paul J Brindley; Jason Mulvenna; Thewarach Laha; Michael J Smout; Eimorn Mairiang; Jeffrey M Bethony; Alex Loukas
Journal:  Trends Parasitol       Date:  2012-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.